Thematic Review Series 2007
Genetic Causes of Bronchiectasis: Primary Ciliary DyskinesiaMorillas H.N. · Zariwala M. · Knowles M.R.
University of North Carolina, Chapel Hill, N.C., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder reflecting abnormalities in the structure and function of motile cilia and flagella, causing impairment of mucociliary clearance, left-right body asymmetry, and sperm motility. Clinical manifestations include respiratory distress in term neonates, recurrent otosinopulmonary infections, bronchiectasis, situs inversus and/or heterotaxy, and male infertility. Genetic discoveries are emerging from family-based linkage studies and from testing candidate genes. Mutations in 2 genes, DNAI1 and DNAH5, frequently cause PCD as an autosomal recessive disorder. A clinical genetic test has been recently established for DNAI1 and DNAH5, which involves sequencing 9 exons that harbor the most common mutations. This approach will identify at least one mutation in these 2 genes in ∼25% of PCD patients. If biallelic mutations are identified, the test is diagnostic. If only one mutation is identified, the full gene may be sequenced to search for a trans-allelic mutation. As more disease-causing gene mutations are identified, broader genetic screening panels will further identify patients with PCD. Ongoing investigations are beginning to identify genetic mutations in novel clinical phenotypes for PCD, such as congenital heart disease and male infertility, and new associations are being established between ‘ciliary’ genetic mutations and clinical phenotypes.
© 2007 S. Karger AG, Basel
- Knowles MR, Boucher RC: Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002;109:571–577.
- Afzelius BA: A human syndrome caused by immotile cilia. Science 1976;193:317–319.
Afzelius BA, Mossberg B, Bergstrom SE: Immotile cilia syndrome (primary ciliary dyskinesia), including Kartagener syndrome; in The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw-Hill, 2001, pp 4817–4827.
- Noone PG, Bennett WD, Regnis JA, Zeman KL, Carson JL, King M, et al: Effect of aerosolized uridine-5′-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. Am J Respir Crit Care Med 1999;160:144–149.
- Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha, M, et al: Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004;169:459–467.
- van’s Gravesande KS, Omran H: Primary ciliary dyskinesia: clinical presentation, diagnosis and genetics. Ann Med 2005;37:439–449.
- Kennedy MP, Noone PG, Carson J, Molina PL, Ghio A, Zariwala MA, et al: Calcium stone lithoptysis in primary ciliary dyskinesia. Respir Med 2007;101:76–83.
- Halbert SA, Patton DL, Zarutskie PW, Soules MR: Function and structure of cilia in the fallopian tube of an infertile woman with Kartagener’s syndrome. Hum Reprod 1997;12:55–58.
- Nonaka S, Tanaka Y, Okada Y, Takeda S, Harada A, Kanai Y, et al: Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 1998;95:829–837.
- Kartagener M, Stucki P: Bronchiectasis with situs inversus. Arch Pediatr 1962;79:193–207.
Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, et al: Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation, in press.
- Leigh MW: Primary ciliary dyskinesia. Semin Respir Crit Care Med 2003;24:653–662.
- Coren ME, Meeks M, Morrison I, Buchdahl RM, Bush A: Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr 2002;91:667–669.
- Ferkol T, Leigh MW: Primary ciliary dyskinesia and newborn respiratory distress. Semin Perinatol 2006;30:335–340.
- Bush A, Cole P, Hariri M, Mackay I, Phillips G, O’Callaghan C, et al: Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J 1998;12:982–988.
- Carda C, Armengot M, Escribano A, Peydro A: Ultrastructural patterns of primary ciliar dyskinesia syndrome. Ultrastruct Pathol 2005;29:3–8.
- Chilvers MA, Rutman A, O’Callaghan C: Ciliary beat pattern is associated with specific ultrastructural defects in primary ciliary dyskinesia. J Allergy Clin Immunol 2003;112:518–524.
- Jorissen M, Willems T, Van der SB Verbeken E, De Boeck K: Ultrastructural expression of primary ciliary dyskinesia after ciliogenesis in culture. Acta Otorhinolaryngol Belg 2000;54:343–356.
- Stannard W, Rutman A, Wallis C, O’Callaghan C: Central microtubular agenesis causing primary ciliary dyskinesia. Am J Respir Crit Care Med 2004;169:634–637.
- Escudier E, Couprie M, Duriez B, Roudot-Thoraval F, Millepied MC, Pruliere-Escabasse V, et al: Computer-assisted analysis helps detect inner dynein arm abnormalities. Am J Respir Crit Care Med 2002;166:1257–1262.
- Carlen B, Stenram U: Primary ciliary dyskinesia: a review. Ultrastruct Pathol 2005;29:217–220.
- Carson JL, Collier AM, Hu S-CS: Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N Engl J Med 1985;312:463–468.
- Lundberg JO, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K: Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. Eur Respir J 1994;7:1501–1504.
- Zariwala MA, Knowles MR, Omran H: Genetic defects in ciliary structure and function. Annu Rev Physiol 2007;69:22.1–22.28.
Satir P: Tour of organelles through the electron microscope: a reprinting of Keith R. Porter’s classic Harvey Lecture with a new introduction. Anat Rec A Discov Mol Cell Evol Biol 2005;287:1184–1185.
- Satir P, Christensen ST: Overview of structure and function of mammalian cilia. Annu Rev Physiol 2007;69:14.1–14.24.
- Brueckner M: Cilia propel the embryo in the right direction. Am J Med Genet 2001;101:339–344.
- Pazour GJ, Agrin N, Leszyk J, Whitman GB: Proteomic analysis of a eukaryotic cilium. J Cell Biol 2005;170:103–113.
- Pazour GJ, Agrin N, Walker BL, Witman GB: Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes. J Med Genet 2006;43:62–73.
- Fliegauf M, Olbrich H, Horvath J, Wildhaber JH, Zariwala MA, Kennedy MP, et al: Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia. Am J Respir Crit Care Med 2005;171:1343–1349.
- Porter ME, Sale WS: The 9 + 2 axoneme anchors multiple inner arm dyneins and a network of kinases and phosphatases that control motility. J Cell Biol 2000;151:F37–F42.
- Blouin JL, Meeks M, Radhakrishna U, Sainsbury A, Gehring C, Sail GD, et al: Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet 2000;8:109–118.
- Pennarun G, Escudier E, Chapelin C, Bridoux AM, Cacheux V, Roger G, et al: Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet 1999;65:1508–1519.
- Mitchell DR, Kang Y: Identification of oda6 as a Chlamydomonas dynein mutant by rescue with the wild-type gene. J Cell Biol 1991;113:835–842.
- Guichard C, Harricane MC, Lafitte JJ, Godard P, Zaegel M, Tack V, et al: Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am J Hum Genet 2001;68:1030–1035.
- Zariwala M, Noone PG, Sannuti A, Minnix S, Zhou Z, Leigh MW, et al: Germline mutations in an intermediate chain dynein cause primary ciliary dyskinesia. Am J Respir Cell Mol Biol 2001;25:577–583.
- Zariwala MA, Leigh MW, Ceppa F, Kennedy MP, Noone PG, Carson JL, et al: Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med 2006;174:858–866.
- Rupp G, O’Toole E, Gardner LC, Mitchell BF, Porter ME: The sup-pf-2 mutations of Chlamydomonas alter the activity of the outer dynein arms by modification of the gamma-dynein heavy chain. J Cell Biol 1996;135:1853–1865.
- Olbrich H, Haffner K, Kispert A, Volkel A, Volz A, Sasmaz G, et al: Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat Genet 2002;30:143–144.
- Hornef N, Olbrich H, Horvath J, Zariwala MA, Fliegauf M, Loges NT, et al: DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med 2006;174:120–126.
- Ferec C, Casals T, Chuzhanova N, Macek M Jr, Bienvenu T, Holubova A, et al: Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet 2006;14:567–576.
- Kispert A, Petry M, Olbrich H, Volz A, Ketelsen UP, Horvath J, et al: Genotype-phenotype correlations in PCD patients carrying DNAH5 mutations. Thorax 2003;58:552–554.
- Bartoloni L, Blouin JL, Pan Y, Gehrig C, Maiti AK, Scamuffa N, et al: Mutations in the DNAH11(axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci USA 2002;99:10282–10286.
- Supp DM, Witte DP, Potter SS, Brueckner M: Mutation of an axonemal dynein affects left-right asymmetry in inversus viscerum mice. Nature 1997;389:963–966.
- Hong DH, Pawlyk BS, Shang J, Sandberg MA, Berson EL, Li T: A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci USA 2000;97:3649–3654.
- Iannaccone A, Breuer DK, Wang XF, Kuo SF, Normando EM, Filippova E, et al: Clinical and immunohistochemical evidence for an X-linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation. J Med Genet 2003;40:e118.
- Moore A, Escudier E, Roger G, Tamalet A, Pelosse B, Marlin S, et al: RPGR is mutated in patients with a complex X-linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet 2006;43:326–333.
- Ferrante MI, Giorgio G, Feather SA, Bulfone A, Wright V, Ghiani M, et al: Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet 2001;68:569–576.
- Ferrante MI, Zullo A, Barra A, Bimonte S, Messaddeq N, Studer M, et al: Oral-facial-digital type I protein is required for primary cilia formation and left-right axis specification. Nat Genet 2006;38:112–117.
- Budny B, Chen W, Omran H, Fliegauf M, Tzschach A, Wisniewska M, Jensen LR, et al: A novel X-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral-facial-digital type I syndrome. Hum Genet 2006;120:171–178.
- Bartoloni L, Blouin JL, Maiti AK, Sainsbury A, Rossier C, Gerhig C, et al: Axonemal beta heavy chain dynein DNAH9: cDNA sequence, genomic structure, and investigation of its role in primary ciliary dyskinesia. Genomics 2001;72:21–33.
Blouin JL, Albrecht C, Gehrig C, Duriaux-Sail G, Strauss JF 3rd, Bartoloni L, et al: Primary ciliary dyskinesia/Kartagener syndrome: searching for genes in a highly heterogeneous disorder (abstract). Am J Hum Genet 2003;73(suppl 5):No 2440.
Bartoloni L, Mitchison H, Pazour GJ, Maiti AK, Meeks M, Chung E, et al: No deleterious mutations were found in three genes (HFH4, LC8, IC2) on human chromosome 17q in patients with primary ciliary dyskinesia (abstract). Eur J Hum Genet 2000;8:P484.
- Pennarun G, Bridoux AM, Escudier E, Dastot-Le Moal F, Cacheux V, Amselem S, et al: Isolation and expression of the human hPF20 gene orthologous to Chlamydomonas PF20: evaluation as a candidate for axonemal defects of respiratory cilia and sperm flagella. Am J Respir Cell Mol Biol 2002;26:362–370.
- Horvath J, Fliegauf M, Olbrich H, Kispert A, King SM, Mitchison H, et al: Identification and analysis of axonemal dynein light chain 1 in primary ciliary dyskinesia patients. Am J Respir Cell Mol Biol 2005;33:41–47.
Gehrig C, Albrecht C, Duriaus Sail G, Rossier C, Scamuffa N, DeLozier-Blancet C, et al: Primary ciliary dyskinesia: mutation analysis in dynein light chain genes mapping to chromosome 1 (HP28) and 22 (DNAL4) (abstract). European Human Genetics Conference, Strasbourg, 2002, P0305.
- Neesen J, Drenckhahn JD, Tiede S, Burfeind P, Grzmil M, Konietzko J, et al: Identification of the human ortholog of the t-complex-encoded protein TCTE3 and evaluation as a candidate gene for primary ciliary dyskinesia. Cytogenet Genome Res 2002;98:38–44.
Blouin JL, Gehrig C, Armengot M, Rutishauser M, Jorissen M, Jeganathan D, et al: DNAH3: characterization of the sequence and mutation search in patients with primary ciliary dyskinesia (abstract). European Human Genetics Conference, Strasbourg, 2002, P0304.
- Zhang YJ, O’Neal WK, Randell SH, Blackburn K, Moyer MB, Boucher R, et al: Identification of dynein heavy chain 7 as an inner arm component of human cilia that is synthesized but not assembled in a case of primary ciliary dyskinesia. J Biol Chem 2002;277:17906–17915.
Knowles MR, Leigh MW, Kennedy MP, Noone PG, Lyons SM, Escudier E, et al: An IDA intermediate chain dynein as a candidate gene for primary ciliary dyskinesia (PCD) (abstract 1815B). American Society of Human Genetics Conference, New Orleans, 2006.
Pennarun G, Bridoux AM, Escudier E, Amselem S, Duriez B: The human HP28 and HFH4 genes: evaluation as candidate genes for primary ciliary dyskinesia (abstract). Am J Respir Crit Care Med 2001;163:A538.
- Zariwala M, O’Neal WK, Noone PG, Leigh MW, Knowles MR, Ostrowski LE: Investigation of the possible role of a novel gene, DPCD, in primary ciliary dyskinesia. Am J Respir Cell Mol Biol 2004;30:428–434.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.